160 related articles for article (PubMed ID: 37467351)
1. Differences in Patterns of Stimulant Use and Their Impact on First-Episode Psychosis Incidence: An Analysis of the EUGEI Study.
Rodríguez-Toscano E; Alloza C; Fraguas D; Durán-Cutilla M; Roldán L; Sánchez-Gutiérrez T; López-Montoya G; Parellada M; Moreno C; Gayer-Anderson C; Jongsma HE; Di Forti M; Quattrone D; Velthorst E; de Haan L; Selten JP; Szöke A; Llorca PM; Tortelli A; Bobes J; Bernardo M; Sanjuán J; Luis Santos J; Arrojo M; Tarricone I; Berardi D; Ruggeri M; Lasalvia A; Ferraro L; La Cascia C; La Barbera D; Menezes PR; Del-Ben CM; ; Rutten BP; van Os J; Jones PB; Murray RM; Kirkbride JB; Morgan C; Díaz-Caneja CM; Arango C
Schizophr Bull; 2023 Sep; 49(5):1269-1280. PubMed ID: 37467351
[TBL] [Abstract][Full Text] [Related]
2. The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study.
Di Forti M; Quattrone D; Freeman TP; Tripoli G; Gayer-Anderson C; Quigley H; Rodriguez V; Jongsma HE; Ferraro L; La Cascia C; La Barbera D; Tarricone I; Berardi D; Szöke A; Arango C; Tortelli A; Velthorst E; Bernardo M; Del-Ben CM; Menezes PR; Selten JP; Jones PB; Kirkbride JB; Rutten BP; de Haan L; Sham PC; van Os J; Lewis CM; Lynskey M; Morgan C; Murray RM;
Lancet Psychiatry; 2019 May; 6(5):427-436. PubMed ID: 30902669
[TBL] [Abstract][Full Text] [Related]
3. Child maltreatment, migration and risk of first-episode psychosis: results from the multinational EU-GEI study.
D'Andrea G; Lal J; Tosato S; Gayer-Anderson C; Jongsma HE; Stilo SA; van der Ven E; Quattrone D; Velthorst E; Berardi D; Rossi Menezes P; Arango C; Parellada M; Lasalvia A; La Cascia C; Ferraro L; La Barbera D; Sideli L; Bobes J; Bernardo M; Sanjuán J; Santos JL; Arrojo M; Del-Ben CM; Tripoli G; Llorca PM; de Haan L; Selten JP; Tortelli A; Szöke A; Muratori R; Rutten BP; van Os J; Jones PB; Kirkbride JB; Murray RM; di Forti M; Tarricone I; Morgan C
Psychol Med; 2023 Oct; 53(13):6150-6160. PubMed ID: 36305570
[TBL] [Abstract][Full Text] [Related]
4. Variation of subclinical psychosis across 16 sites in Europe and Brazil: findings from the multi-national EU-GEI study.
D'Andrea G; Quattrone D; Malone K; Tripoli G; Trotta G; Spinazzola E; Gayer-Anderson C; Jongsma HE; Sideli L; Stilo SA; La Cascia C; Ferraro L; Lasalvia A; Tosato S; Tortelli A; Velthorst E; de Haan L; Llorca PM; Rossi Menezes P; Santos JL; Arrojo M; Bobes J; Sanjuán J; Bernardo M; Arango C; Kirkbride JB; Jones PB; Rutten BP; Van Os J; Selten JP; Vassos E; Schürhoff F; Szöke A; Pignon B; O'Donovan M; Richards A; Morgan C; Di Forti M; Tarricone I; Murray RM
Psychol Med; 2024 Jun; 54(8):1810-1823. PubMed ID: 38288603
[TBL] [Abstract][Full Text] [Related]
5. Differences in cannabis-related experiences between patients with a first episode of psychosis and controls.
Bianconi F; Bonomo M; Marconi A; Kolliakou A; Stilo SA; Iyegbe C; Gurillo Muñoz P; Homayoun S; Mondelli V; Luzi S; Dazzan P; Prata D; La Cascia C; O'Connor J; David A; Morgan C; Murray RM; Lynskey M; Di Forti M
Psychol Med; 2016 Apr; 46(5):995-1003. PubMed ID: 26670601
[TBL] [Abstract][Full Text] [Related]
6. Tobacco use in first-episode psychosis, a multinational EU-GEI study.
Sánchez-Gutiérrez T; Rodríguez-Toscano E; Roldán L; Ferraro L; Parellada M; Calvo A; López G; Rapado-Castro M; La Barbera D; La Cascia C; Tripoli G; Di Forti M; Murray RM; Quattrone D; Morgan C; van Os J; García-Portilla P; Al-Halabí S; Bobes J; de Haan L; Bernardo M; Santos JL; Sanjuán J; Arrojo M; Ferchiou A; Szoke A; Rutten BP; Stilo S; D'Andrea G; Tarricone I; ; Díaz-Caneja CM; Arango C
Psychol Med; 2023 Nov; 53(15):7265-7276. PubMed ID: 37185055
[TBL] [Abstract][Full Text] [Related]
7. Stimulant use disorders in people with psychosis: a meta-analysis of rate and factors affecting variation.
Sara GE; Large MM; Matheson SL; Burgess PM; Malhi GS; Whiteford HA; Hall WD
Aust N Z J Psychiatry; 2015 Feb; 49(2):106-17. PubMed ID: 25518844
[TBL] [Abstract][Full Text] [Related]
8. The impact of cannabis use on age of onset and clinical characteristics in first-episode psychotic patients. Data from the Psychosis Incident Cohort Outcome Study (PICOS).
Tosato S; Lasalvia A; Bonetto C; Mazzoncini R; Cristofalo D; De Santi K; Bertani M; Bissoli S; Lazzarotto L; Marrella G; Lamonaca D; Riolo R; Gardellin F; Urbani A; Tansella M; Ruggeri M;
J Psychiatr Res; 2013 Apr; 47(4):438-44. PubMed ID: 23290558
[TBL] [Abstract][Full Text] [Related]
9. Association of Environment With the Risk of Developing Psychotic Disorders in Rural Populations: Findings from the Social Epidemiology of Psychoses in East Anglia Study.
Richardson L; Hameed Y; Perez J; Jones PB; Kirkbride JB
JAMA Psychiatry; 2018 Jan; 75(1):75-83. PubMed ID: 29188295
[TBL] [Abstract][Full Text] [Related]
10. Differences in associations between cannabis and stimulant disorders in first admission psychosis.
Sara G; Burgess P; Malhi GS; Whiteford H; Hall W
Schizophr Res; 2013 Jul; 147(2-3):216-22. PubMed ID: 23684162
[TBL] [Abstract][Full Text] [Related]
11. Proportion of patients in south London with first-episode psychosis attributable to use of high potency cannabis: a case-control study.
Di Forti M; Marconi A; Carra E; Fraietta S; Trotta A; Bonomo M; Bianconi F; Gardner-Sood P; O'Connor J; Russo M; Stilo SA; Marques TR; Mondelli V; Dazzan P; Pariante C; David AS; Gaughran F; Atakan Z; Iyegbe C; Powell J; Morgan C; Lynskey M; Murray RM
Lancet Psychiatry; 2015 Mar; 2(3):233-8. PubMed ID: 26359901
[TBL] [Abstract][Full Text] [Related]
12. Daily use of high-potency cannabis is associated with more positive symptoms in first-episode psychosis patients: the EU-GEI case-control study.
Quattrone D; Ferraro L; Tripoli G; La Cascia C; Quigley H; Quattrone A; Jongsma HE; Del Peschio S; Gatto G; ; Gayer-Anderson C; Jones PB; Kirkbride JB; La Barbera D; Tarricone I; Berardi D; Tosato S; Lasalvia A; Szöke A; Arango C; Bernardo M; Bobes J; Del Ben CM; Menezes PR; Llorca PM; Santos JL; Sanjuán J; Tortelli A; Velthorst E; de Haan L; Rutten BPF; Lynskey MT; Freeman TP; Sham PC; Cardno AG; Vassos E; van Os J; Morgan C; Reininghaus U; Lewis CM; Murray RM; Di Forti M
Psychol Med; 2021 Jun; 51(8):1329-1337. PubMed ID: 32183927
[TBL] [Abstract][Full Text] [Related]
13. Cannabis Use Is Associated With Increased Psychotic Symptoms and Poorer Psychosocial Functioning in First-Episode Psychosis: A Report From the UK National EDEN Study.
Seddon JL; Birchwood M; Copello A; Everard L; Jones PB; Fowler D; Amos T; Freemantle N; Sharma V; Marshall M; Singh SP
Schizophr Bull; 2016 May; 42(3):619-25. PubMed ID: 26536902
[TBL] [Abstract][Full Text] [Related]
14. Relationships between patterns of cannabis use, abuse and dependence and recent stimulant use: Evidence from two national surveys in Ireland.
Millar SR; Mongan D; O'Dwyer C; Smyth BP; Perry IJ; Galvin B
PLoS One; 2021; 16(8):e0255745. PubMed ID: 34370775
[TBL] [Abstract][Full Text] [Related]
15. Prescription stimulant use is associated with earlier onset of psychosis.
Moran LV; Masters GA; Pingali S; Cohen BM; Liebson E; Rajarethinam RP; Ongur D
J Psychiatr Res; 2015 Dec; 71():41-7. PubMed ID: 26522870
[TBL] [Abstract][Full Text] [Related]
16. First episode of psychosis in Guam: The role of ethnicity and neighbourhood factors.
Rosenfarb IF; Sharma-Gopinath R; Bhavsar V
Early Interv Psychiatry; 2022 Jun; 16(6):618-625. PubMed ID: 34414657
[TBL] [Abstract][Full Text] [Related]
17. Cognitive functioning and cannabis use in first-episode psychosis.
Karpov B; Lindgren M; Kieseppä T; Wegelius A; Suvisaari J
Nord J Psychiatry; 2022 Oct; 76(7):551-558. PubMed ID: 34964681
[TBL] [Abstract][Full Text] [Related]
18. Incidence rate and distinctive characteristics of first episode psychosis during the COVID-19 pandemic: a multicenter observational study.
Casanovas F; Trabsa A; Bergé D; Sánchez-Gistau V; Moreno I; Sanchez J; Montalvo I; Tost M; Labad J; Pérez-Solà V; Mané A
Sci Rep; 2022 Dec; 12(1):22036. PubMed ID: 36543820
[TBL] [Abstract][Full Text] [Related]
19. Impact of previous tobacco use with or without cannabis on first psychotic experiences in patients with first-episode psychosis.
González-Blanco L; García-Portilla MP; Gutiérrez M; Mezquida G; Cuesta MJ; Urbiola E; Amoretti S; Barcones F; González-Pinto A; Pina-Camacho L; Corripio I; Vieta E; Baeza I; Toll A; Sáiz PA; Bobes J; Bernardo M;
Schizophr Res; 2021 Oct; 236():19-28. PubMed ID: 34365082
[TBL] [Abstract][Full Text] [Related]
20. Childhood abuse in the etiological continuum underlying psychosis from first-episode psychosis to psychotic experiences.
Alemany S; Ayesa-Arriola R; Arias B; Fatjó-Vilas M; Ibáñez MI; Ortet G; Crespo-Facorro B; Fañanás L
Eur Psychiatry; 2015 Jan; 30(1):38-42. PubMed ID: 25284334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
